Stay up to date on novel, clinically-relevant research findings in Parkinson’s disease and other movement disorders.
Alpha-synuclein based biomarkers have dominated the Parksinon’s disease field over the past few years. Dr. Andrew Siderowf shares his views on the future of these biomarkers and what else...
Dr. Aasef Shaikh shares the exciting developments in the world of tremor and how he believes the use of technology will help answer some of the field’s big questions,...
Dr. Alexander Lehn breaks down functional movement disorders; what is happening in the brain, what are the potential risk factors and what future treatments and clinical trials we have...
Dr. Kishore Kumar shares the new genes associated with Parkinson’s disease, dystonia, and ataxia. He also shares how new technologies, like long read sequencing, can assist in finding epigenetic...
Prof. Jeffrey Kordower shares the data in support of #PD being a copathology disease and what strategies may be in the future for protein aggregate clearance in age-related neurodegenerative...
Prof. Brit Mollenhauer shares her excitement about basic science, including biomarker research, and how she believes MDS’s diversity can help foster more collaboration between clinicians and basic scientists.
Dr. Günter Höglinger discusses new genetic findings and other exciting research surrounding PSP and other atypical parkinsonisms.
Dr. Sara Schaefer interviews Dr. Jennifer Goldman about her systematic review and meta-analysis on subjective cognitive complaints in Parkinson’s disease, including the prevalence, epidemiology, and correlation with objective cognitive...
Award Replay: Dr. Eduardo Fernandez interviews Professor Günther Deuschl and Dr. Robin Wolke on their article on the challenges levodopa poses when predicting the outcome of subthalamic deep brain...